福永 興壱

Medicine & Life Sciences

1. Asthma 100%
2. Coronavirus 88%
3. Lung 80%
4. Inflammation 62%
5. Eosinophils 56%
6. Pneumonia 54%
7. Chronic Obstructive Pulmonary Disease 53%
8. Japan 48%
9. Mycobacterium avium Complex 44%
10. Non-Small Cell Lung Carcinoma 42%
11. Lung Neoplasms 41%
12. Acute Lung Injury 41%
13. Standing Position 37%
14. Bronchoalveolar Lavage Fluid 33%
15. Tomography 32%
16. Supine Position 32%
17. Obstructive Sleep Apnea 32%
18. Therapeutics 31%
19. Platelet Activating Factor 31%
20. presqualene pyrophosphate 31%
21. Severe Acute Respiratory Syndrome 29%
22. cysteinyl-leukotriene 27%
23. Cyclooxygenase 2 26%
24. prostaglandin D2 receptor 26%
25. Smartphone 26%
26. 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid 26%
27. Adrenal Cortex Hormones 24%
28. Ovalbumin 24%
29. lipoxin A4 24%
30. pranlukast 24%
31. Respiratory Function Tests 24%
32. Adenocarcinoma of Lung 23%
33. Phenotype 23%
34. Smoking Cessation 21%
35. Lymphocytes 21%
36. Lipopolysaccharides 21%
37. Lung Injury 21%
38. Smoke 21%
39. Allergic Bronchopulmonary Aspergillosis 21%
40. Interleukin-33 21%
41. Tobacco Products 21%
42. Serum 21%
43. Apnea 20%
44. Multicenter Studies 20%
45. Lung Diseases 19%
46. Smooth Muscle Myocytes 19%
47. Allergens 19%
48. Cytokines 19%
49. Interstitial Lung Diseases 18%
50. Interleukin-23 18%